End of the line for “third-generation-pill” controversy?
Open Access
- 19 April 1997
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 349 (9059) , 1113-1114
- https://doi.org/10.1016/s0140-6736(05)63015-2
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second‐ and third‐generation oral contraceptivesBritish Journal of Haematology, 1997
- Oral contraceptives and thrombotic diseases: Impact of new epidemiological studiesContraception, 1996
- Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagenThe Lancet, 1995